Navigation Links
California Grants SeqWright License to Operate as a Clinical Laboratory
Date:3/10/2009

HOUSTON, March 10 /PRNewswire/ -- SeqWright, a world-wide leader in custom genomic and molecular biology services, announced today that it has been granted a California clinical laboratory license. This license enables SeqWright to utilize its DNA sequencing and Single Nucleotide Polymorphism (SNP) Genotyping expertise in order to provide genetic tests to California residents and represents a significant step forward in the shift towards personalized medicine. With its CLIA certification and a California clinical laboratory license, SeqWright is capable of performing validated genetic tests on individuals throughout the majority of the United States.

As personalized medicine becomes a more prominent component of modern healthcare, SeqWright stands poised to leverage its significant experience in molecular biology and genomic analysis services in order to expand its share of the market for personalized genetic tests. However, it is important to note that SeqWright generally does not develop and market such tests internally and therefore, its role would be that of a support laboratory working with industry partners on previously developed and validated assays.

On a similar note, SeqWright has recently been named as an Authorized Service Provider for NimbleGen Capture Arrays. These arrays enable whole-exome and custom-targeted enrichment of genomic DNA. The enriched genomic DNA can then be sequenced on one of SeqWright's two types of next generation genomic analysis platforms; AB SOLiD or 454 Titanium for analysis. This capability opens up the potential for a quantum leap in personalized medicine within the near future by dramatically decreasing the time and cost associated with sequencing all coding DNA (the exome) as well as custom-targeted regions within an individual's genome.

About SeqWright

Based in Houston, TX, SeqWright Incorporated is a world-class provider of genomic analysis services, including next generation sequencing. SeqWright has more than fifteen years of experience specializing in state of the art Molecular Biology and Genomic services within a highly regulated GLP/CLIA environment. For additional information about SeqWright and its services, please visit www.seqwright.com.


'/>"/>
SOURCE SeqWright Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Transgenomic Awarded Clinical Laboratory Certification in California
2. AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years
3. Tully-Wihr Company Selects Web-Based Allscripts Electronic Health Record for 100 Northern California Physicians
4. Convey Computer™ Corporation Announces First Customer: University of California, San Diego at SC08 Conference
5. California State Senator Shelia Kuehls Leadership in Stem Cell Debate Praised and Embryonic Stem Cell Profiteers Criticized by Repair Stem Cell Institute Spokesman
6. University of Southern California Receives Cancer Diagnosis System for Detecting Esophageal Dysplasia
7. ALS Therapy Development Institute and California Stem Cell, Inc. Announce Long-Term Scientific Collaboration
8. Phlo Affiliate Announces Significant Distribution Expansion In California
9. Californias International Stem Cell Collaborations Must Be Based on Scientific Merit, Consumer Group Says
10. Controllers Stem Cell Agency Audit Ignores California Agencys Built-in Flaws
11. Nikon Instruments Begins Direct Sales and Technical Support in Southern California and Rocky Mountain Territories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... 2017 , ... NextSteps 2017, NetDimensions’ annual global user conference, ... May on the following dates: , ?    London, UK from May 10-11, ?    New Orleans, ... Performance Institute will be the opening keynote speaker at the NextSteps EMEA ...
(Date:4/25/2017)... Yorba Linda, Ca (PRWEB) , ... April 25, 2017 , ... ... latest webinar in the series will explore the laboratory testing for DIC in order ... a serious hypercoagulable disorder which can occur in hospitalized patients resulting in a high ...
(Date:4/25/2017)... , April 25, 2017 ... ("EpiVax") has licensed its novel immune-modulating technology to an ... disease and allergy. Tregitopes, pronounced T·rej·itopes, ... human immunoglobulin by EpiVax CEO Annie De ... to intravenous immunoglobulin G, an autoimmune disease therapy, ...
(Date:4/25/2017)... ... ... Leaders of Quorum Review IRB and Kinetiq , the consulting ... Association of Clinical Research Professionals (ACRP) 2017 Meeting & Expo with topics ... excited to present subject matter expertise on topics that impact the global clinical research ...
Breaking Biology Technology:
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/29/2017)... , March 29, 2017  higi, the health ... in North America , today announced ... and the acquisition of EveryMove. The new investment and ... set of tools to transform population health activities through ... lifestyle data. higi collects and secures data ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
Breaking Biology News(10 mins):